Approvals/CIMA-AEMPS/ATECTURA BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA)

Approved

STANDARD

ATECTURA BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA)

Novartis Europharm Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: c2cbf54208c8f92b
Drug Cima Aemps Name: ATECTURA BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA)
Register Number: 1201439010
Holder Company Name: Novartis Europharm Limited
Marketing Company Name: Laboratorios Menarini S.A.
Holder Company Detail Path: /organization/novartis-europharm-limited
Authorization Date: 2020-08-09
Dosage Form: POLVO PARA INHALACIÓN (CÁPSULA DURA)
Dose: 125/260 µg
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Novartis Europharm Limited
Company Detail Path: /organization/novartis-europharm-limited

INDACATEROL ACETATO

0,173 mg

MOMETASONA FUROATO

0,320 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 9, 2020

Approval ID

c2cbf54208c8f92b

Type

Standard